Viewing StudyNCT01015911



Ignite Creation Date: 2024-05-05 @ 10:03 PM
Last Modification Date: 2024-10-26 @ 10:13 AM
Study NCT ID: NCT01015911
Status: COMPLETED
Last Update Posted: 2014-12-18
First Post: 2009-11-13

Brief Title: A Phase 1 Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma
Sponsor: Seagen Inc
Organization: Seagen Inc

Conditions & Keywords Data

Conditions:
Name
Lymphoma Non-Hodgkin
Carcinoma Renal Cell
Keywords:
Name View
monomethylauristatin F View
Antibodies Monoclonal View
Antibody-Drug Conjugate View
Antigens CD70 View
Lymphoma Non-Hodgkin View
Carcinoma Renal Cell View
Immunotherapy View
Drug Therapy View